| Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced … SE Al-Batran, N Homann, C Pauligk, TO Goetze, J Meiler, S Kasper, ... The Lancet 393 (10184), 1948-1957, 2019 | 1929 | 2019 |
| Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study JN Kather, J Krisam, P Charoentong, T Luedde, E Herpel, CA Weis, ... PLoS medicine 16 (1), e1002730, 2019 | 748 | 2019 |
| Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients … SE Al-Batran, RD Hofheinz, C Pauligk, HG Kopp, GM Haag, KB Luley, ... The lancet oncology 17 (12), 1697-1708, 2016 | 712 | 2016 |
| Multi-class texture analysis in colorectal cancer histology JN Kather, CA Weis, F Bianconi, SM Melchers, LR Schad, T Gaiser, ... Scientific reports 6 (1), 1-11, 2016 | 462 | 2016 |
| Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma G Auf, A Jabouille, S Guérit, R Pineau, M Delugin, M Bouchecareilh, ... Proceedings of the National Academy of Sciences 107 (35), 15553-15558, 2010 | 351 | 2010 |
| Topography of cancer-associated immune cells in human solid tumors JN Kather, M Suarez-Carmona, P Charoentong, CA Weis, D Hirsch, ... Elife 7, e36967, 2018 | 254 | 2018 |
| LGR5 positivity defines stem-like cells in colorectal cancer D Hirsch, N Barker, N McNeil, Y Hu, J Camps, K McKinnon, H Clevers, ... Carcinogenesis 35 (4), 849-858, 2014 | 184 | 2014 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 169 | 2022 |
| Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up T Gaiser, H Kutzner, G Palmedo, MD Siegelin, T Wiesner, T Bruckner, ... Modern Pathology 23 (3), 413-419, 2010 | 156 | 2010 |
| Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy M Hofmann, O Stoss, T Gaiser, H Kneitz, P Heinmöller, T Gutjahr, ... Journal of clinical pathology 61 (1), 89-94, 2008 | 153 | 2008 |
| Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma D Hirsch, R Kemmerling, S Davis, J Camps, PS Meltzer, T Ried, T Gaiser Cancer research 73 (5), 1454-1460, 2013 | 113 | 2013 |
| Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation D Capper, T Gaiser, C Hartmann, A Habel, W Mueller, C Herold-Mende, ... Acta neuropathologica 117, 445-456, 2009 | 113 | 2009 |
| COX-2 expression in malignant melanoma: a novel prognostic marker? MR Becker, MD Siegelin, R Rompel, AH Enk, T Gaiser Melanoma research 19 (1), 8-16, 2009 | 102 | 2009 |
| Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system L Lee, U Ronellenfitsch, WL Hofstetter, G Darling, T Gaiser, C Lippert, ... Journal of the American College of Surgeons 217 (2), 191-199, 2013 | 95 | 2013 |
| P53‐induced miR‐30e‐5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1 S Laudato, N Patil, ML Abba, JH Leupold, A Benner, T Gaiser, A Marx, ... International journal of cancer 141 (9), 1879-1890, 2017 | 93 | 2017 |
| Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for … SE Al-Batran, S Lorenzen, PC Thuss-Patience, N Homann, M Schenk, ... Journal of Clinical Oncology 40 (16_suppl), 4003-4003, 2022 | 90 | 2022 |
| Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA … RD Hofheinz, GM Haag, TJ Ettrich, K Borchert, A Kretzschmar, ... Journal of Clinical Oncology 38 (15_suppl), 4502-4502, 2020 | 88 | 2020 |
| A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men G Petrovics, H Li, T Stümpel, SH Tan, D Young, S Katta, Q Li, K Ying, ... EBioMedicine 2 (12), 1957-1964, 2015 | 77 | 2015 |
| The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP MD Siegelin, T Gaiser, Y Siegelin Neurochemistry International 55 (6), 423-430, 2009 | 72 | 2009 |
| Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2 MD Siegelin, T Gaiser, A Habel, Y Siegelin Cancer letters 283 (2), 230-238, 2009 | 65 | 2009 |
